论文部分内容阅读
脑血管疾病是危害人类健康的一种常见多发病,已引起国内外越来越多的重视。近年来,脑缺血性疾病在脑血管疾病中的发病率已有超过脑出血性疾病的趋势,占脑血管疾病总发病率的57—62%。国内有人报告脑血栓的发病与脑出血之比为1.25、1972年以来,灯盏花[Erigeron breviscapus(vaniot)Hand—Mazz]已用于临床治疗脑血管疾病及其后遗症——瘫痪,收到良好效果,总有效率可达88.5%,特别是对脑血栓形成疗效更好。为探索其疗效机理,我们进行了灯盏花83101(以下简称83101)对软脑膜急性微循环障碍影响的实验研究。
Cerebrovascular disease is a common and frequently occurring disease endangering human health and has attracted more and more attention both at home and abroad. In recent years, the incidence of cerebral ischemic disease in cerebrovascular diseases has exceeded that of cerebral hemorrhagic diseases, accounting for 57-62% of the total incidence of cerebrovascular diseases. Domestic incidence of cerebral thrombosis and cerebral hemorrhage was reported 1.25, since 1972, Erigeron breviscapus (vaniot) Hand-Mazz] has been used in clinical treatment of cerebrovascular disease and its aftermath - paralyzed, and received good results , The total efficiency up to 88.5%, especially for cerebral thrombosis better. To explore the mechanism of its efficacy, we conducted a pilot study of the Erigeron breviscapus 83101 (hereinafter referred to as 83101) on the impact of acute meningeal microcirculation.